1 |
Yang YC, Chang TY, Chen TC, et al (2013). Genetic variants in interleukin-18 gene and risk for cervical squamous cell carcinoma. Human Immunology, 74, 882-7.
DOI
ScienceOn
|
2 |
Zeng H, Zheng R, Zhang S, et al (2014). Female breast cancer statistics of 2010 in China: estimates based on data from 145 population-based cancer registries. J Thorac Dis, 6, 466-70.
|
3 |
Cochran WG (1968). The effectiveness of adjustment by subclassification in removing bias in observational studies. Biometrics, 24, 295-313.
DOI
ScienceOn
|
4 |
Couch FJ, Sinilnikova O, Vierkant RA, et al (2007). AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study. Cancer Epidemiol Biomarkers Prev, 16, 1416-21.
DOI
|
5 |
Cox DG, Hankinson SE, Hunter DJ (2006). Polymorphisms of the AURKA (STK15/Aurora Kinase) Gene and Breast Cancer Risk (United States). Cancer Causes Control, 17, 81-3.
DOI
|
6 |
Dai Q, Cai QY, Shu XO, et al (2004). Synergistic effects of STK15 gene polymorphisms and endogenous estrogen exposure in the risk of breast cancer. Cancer Epidemiol Biomarkers Prev, 13, 2065-70.
|
7 |
DeSantis C, Ma J, Bryan L, et al (2014). Breast cancer statistics, 2013. CA Cancer J Clin, 64, 52-62.
DOI
ScienceOn
|
8 |
Egan KM, Newcomb PA, Ambrosone CB, et al (2004). STK15 polymorphism and breast cancer risk in a population-based study. Carcinogenesis, 25, 2149-53.
DOI
|
9 |
Egger M, Davey Smith G, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
DOI
ScienceOn
|
10 |
Ewart-Toland A, Dai Q, Gao YT, et al (2005). Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types. Carcinogenesis, 26, 1368-73.
DOI
|
11 |
Fletcher O, Johnson N, Palles C, et al (2006). Inconsistent association between the STK15 F31I genetic polymorphism and breast cancer risk. J Natl Cancer Inst, 98, 1014-8.
DOI
|
12 |
MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk (2010). Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women. Breast Cancer Res Treat, 120, 727-36.
DOI
|
13 |
Guo XG, Xia Y (2013). The Interleukin-18 promoter -607C>A polymorphism contributes to nasopharyngeal carcinoma risk: evidence from a meta-analysis including 1, 886 subjects. Asian Pac J Cancer Prev, 14, 7577-81.
과학기술학회마을
DOI
ScienceOn
|
14 |
Lo YL, Yu JC, Chen ST, et al (2005). Breast cancer risk associated with genotypic polymorphism of the mitosisregulating gene Aurora-A/STK15/BTAK. Int J Cancer, 115, 276-83.
DOI
|
15 |
Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
|
16 |
Miyoshi Y, Iwao K, Egawa C, et al (2001). Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers. Int J Cancer, 92, 370-3.
DOI
|
17 |
Qin K, Wu C, Wu X (2013). Two nonsynonymous polymorphisms (F31I and V57I) of the STK15 gene and breast cancer risk: a meta-analysis based on 5966 cases and 7609 controls. J Int Med Res, 41, 956-63.
DOI
|
18 |
Ruan Y, Song AP, Wang H, et al (2011). Genetic polymorphisms in AURKA and BRCA1 are associated with breast cancer susceptibility in a Chinese Han population. J Pathol, 225, 535-43.
DOI
|
19 |
Siegel R, Ma J, Zou Z, et al (2014). Cancer statistics, 2014. CA Cancer J Clin, 64, 9-29.
DOI
|
20 |
Siegel R, Naishadham D, Jemal A (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30.
DOI
ScienceOn
|
21 |
Tchatchou S, Wirtenberger M, Hemminki K, et al (2007). Aurora kinases A and B and familial breast cancer risk. Cancer Lett, 247, 266-72.
DOI
|
22 |
Stuck AE, Rubenstein LZ, Wieland D (1998). Bias in metaanalysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ, 316, 70-1.
|
23 |
Sun T, Miao X, Wang J, et al (2004). Functional Phe31Ile polymorphism in Aurora A and risk of breast carcinoma. Carcinogenesis, 25, 2225-30.
DOI
|
24 |
Tang W, Qiu H, Ding H, et al (2013). Association between the STK15 F31I polymorphism and cancer susceptibility: a meta-analysis involving 43, 626 subjects. PLoS One, 8, e82790.
DOI
|
25 |
Thakkinstian A, McElduff P, D'Este C, et al (2005). A method for meta-analysis of molecular association studies. Stat Med, 24, 1291-306.
DOI
ScienceOn
|
26 |
Vidarsdottir L, Bodvarsdottir SK, Hilmarsdottir H, et al (2007). Breast cancer risk associated with AURKA 91T >A polymorphism in relation to BRCA mutations. Cancer Lett, 250, 206-12.
DOI
|
27 |
Wu LZ, Han RQ, Zhou JY, et al (2014). Incidence and mortality of female breast cancer in Jiangsu, China. Asian Pac J Cancer Prev, 15, 2727-32.
과학기술학회마을
DOI
|
28 |
Xia Y, Guo XG, Ji TX (2014). The G801A polymorphism in the CXCL12 gene and risk of breast carcinoma: evidence from a meta-analysis including 2, 931 subjects. Asian Pac J Cancer Prev, 15, 2857-61.
과학기술학회마을
DOI
|
29 |
Xu L, Zhou X, Jiang F, et al (2013). STK15 rs2273535 polymorphism and cancer risk: A meta-analysis of 74, 896 subjects. Cancer Epidemiol, 38, 111-17.
|
30 |
Shi H, Bevier M, Johansson R, et al (2011). Single nucleotide polymorphisms in the 20q13 amplicon genes in relation to breast cancer risk and clinical outcome. Breast Cancer Res Treat, 130, 905-16.
DOI
|